Opthea Ltd has released a press release.
Response to ASX Query
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Opthea
- Opthea Ph2b Trial Results with OPT-302 published in Journal
- Opthea Corporate Presentation - San Francisco Jan 2023
- Chairmans Address to Shareholders
- Completion of Share Purchase Plan
- Opthea reports Fiscal Year 2022 Results and Highlights
Later from Opthea
- Half Year Accounts
- Opthea Receives A$8.7million R&D Tax Incentive
- ASRS 2023 - PK and safety of sozinibercept (OPT-302)
- Opthea announces A$80m Capital raise
- Opthea Investor Presentation
Follow Opthea into a list and get an email when it puts out news.
Follow Opthea